Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Malcolm A. Bagshaw"'
Publikováno v:
Journal of Urology. 167:990-998
The charts of 310 consecutive patients with localized prostatic carcinoma treated definitively with small-field external-beam irradiation were reviewed. The 5- and 10-year uncorrected actuarial survival rates for patients with disease limited to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf9ed4011f2845384c0fd6cf50d8e29
https://doi.org/10.1016/s0022-5347(02)80322-6
https://doi.org/10.1016/s0022-5347(02)80322-6
Autor:
Horst Zincke, Erik J. Bergstralh, Michael J. Barry, Steven J. Jacobsen, Richard S. Cox, Michael L. Blute, Donald F. Gleason M.D., Malcolm A. Bagshaw, Peter C. Albertsen, Richard G. Middleton
Publikováno v:
Cancer. 91:2302-2314
BACKGROUND With a lack of data from randomized trials, the optimal management of men with nonmetastatic prostate carcinoma is controversial. The authors sought to define the outcomes of three common strategies for managing patients with nonmetastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c8194ea62dfb985bfbff230a8fba035
https://doi.org/10.1002/1097-0142(20010615)91:12<2302::aid-cncr1262>3.0.co
https://doi.org/10.1002/1097-0142(20010615)91:12<2302::aid-cncr1262>3.0.co
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 41:735-740
Purpose: To evaluate whether transient androgen deprivation improves outcome in patients irradiated after radical prostatectomy for locally advanced disease, persistent or rising postoperative prostate specific antigen (PSA), or local recurrence. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e495df1e7bcb7edebf2ce1e7e3df51f8
https://doi.org/10.1016/s0360-3016(98)00127-8
https://doi.org/10.1016/s0360-3016(98)00127-8
Publikováno v:
The Journal of Urology. :1412-1417
Purpose: We evaluated prostate specific antigen (PSA) evidence for control of prostatic cancer after irradiation.Materials and Methods: We studied 110 patients for whom more than 2 PSA measurements were obtained to establish trends and the initial me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e940917cca55690f9deeb343c8dabe2
https://doi.org/10.1097/00005392-199510000-00043
https://doi.org/10.1097/00005392-199510000-00043
Publikováno v:
Journal of Urology. 149:519-522
Between 1986 and 1989, 117 patients with pretreatment and serial posttreatment prostate specific antigen values received external beam radiotherapy at our hospital. Followup ranged from 0.6 to 5.9 years (mean 2.7). No patient had hormonal manipulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6526b94b77ec91629b25ac6c616d952b
https://doi.org/10.1016/s0022-5347(17)36133-5
https://doi.org/10.1016/s0022-5347(17)36133-5
Publikováno v:
Journal of Urology. 147:917-921
In a retrospective analysis of 946 patients with prostatic carcinoma treated with external beam radiotherapy between 1958 and 1989 at Stanford University Hospital the 15-year actuarial clinical local control rate was 77.8 ± 3.3% for Stanford stage T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17e8f9b8fdf816c5a11f1b1dc124c2a
https://doi.org/10.1016/s0022-5347(17)37422-0
https://doi.org/10.1016/s0022-5347(17)37422-0
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 23:413-418
Stereotaxic radiosurgery delivered from a modified 4 MV linear accelerator was used to treat 47 brain metastases in 27 patients at Stanford. Response was assessed in 41 lesions. Histopathologies included adenocarcinoma (24 lesions), renal cell carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53dbb5be44adbc99b0649e3aa032273c
https://doi.org/10.1016/0360-3016(92)90762-7
https://doi.org/10.1016/0360-3016(92)90762-7
Publikováno v:
Cancer. 68:400-405
Serial prostatic specific antigen values (PSA) were determined on 42 patients receiving definitive radiation therapy for localized adenocarcinoma of the prostate. The PSA declined exponentially in 25 patients. None of these patients experienced metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0594df4f12e30ff2f572c5afba8c0f1f
https://doi.org/10.1002/1097-0142(19910715)68:2<400::aid-cncr2820680231>3.0.co
https://doi.org/10.1002/1097-0142(19910715)68:2<400::aid-cncr2820680231>3.0.co